Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Irix Pharmaceuticals

1996 FOUNDED
M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of pharmaceutical products. The company is a small-molecule contract research and manufacturing organization (CRMO) working with healthcare industry clients to bring new drugs to market. The company engages in the generation of process technology for new and existing drugs, and the production of active pharmaceutical ingredients (APIs).

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 101 Technology Place
  • Florence, SC 29501
  • United States

Irix Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Irix Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Irix Pharmaceuticals Executive Team (3)

Name Title Board
Seat
Contact
Info
J. Guy Steenrod Chief Executive Officer & Co-Founder
Panayiotis Kalaritis Ph.D Chief Operating Officer & Co-Founder
George Yiannikouros Ph.D Chief Scientific Officer